Skip to Content Skip to Search

Innovation and R&D leadership during COVID19

Our CSO and President, R&D, Hal Barron joined John Carroll from Endpoints News at the Biotechnology Innovation Conventions’ virtual summit to discuss R&D leadership during the #COVID19 pandemic. Hal joined a panel of top R&D execs to discuss how they've reorganized global teams, tapped new programs as a priority to fight Covid-19 and are planning for the future after the pandemic has passed.

Necessity is the mother of innovation."

Watch the full panel discussion

Curious to know how we’re fighting COVID-19 at GSK and across the industry? Hal Barron, our CSO and President, R&D shares more with John Carrol of Endpoints News and other R&D executives across the industry.